|
1
|
Wolfgang CL, Herman JM, Laheru DA, Klein
AP, Erdek MA, Fishman EK and Hruban RH: Recent progress in
pancreatic cancer. CA Cancer J Clin. 63:318–348. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Veisani Y, Jenabi E, Khazaei S and
Nematollahi S: Global incidence and mortality rates in pancreatic
cancer and the association with the human development index:
Decomposition approach. Public Health. 156:87–91. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lin QJ, Yang F, Jin C and Fu DL: Current
status and progress of pancreatic cancer in China. World J
Gastroenterol. 21:7988–8003. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wu AA, Jaffee E and Lee V: Current status
of immunotherapies for treating pancreatic cancer. Curr Oncol Rep.
21:602019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Moutinho-Ribeiro P, Macedo G and Melo SA:
Pancreatic cancer diagnosis and management: Has the time come to
prick the bubble? Front Endocrinol (Lausanne). 9:7792019.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rahib L, Fleshman JM, Matrisian LM and
Berlin JD: Evaluation of pancreatic cancer clinical trials and
benchmarks for clinically meaningful future trials: A systematic
review. JAMA Oncol. 2:1209–1216. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ilic M and Ilic I: Epidemiology of
pancreatic cancer. World J Gastroenterol. 22:9694–9705. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jeune F, Coriat R, Prat F, Dousset B,
Vaillant JC and Gaujoux S: Pancreatic cancer surgical management.
Presse Med. 48:e147–e158. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Marigo V, Roberts DJ, Lee SM, Tsukurov O,
Levi T, Gastier JM, Epstein DJ, Gilbert DJ, Copeland NG and Seidman
CE: Cloning, expression, and chromosomal location of SHH and IHH:
Two human homologues of the Drosophila segment polarity gene
hedgehog. Genomics. 28:44–51. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rimkus TK, Carpenter RL, Qasem S, Chan M
and Lo HW: Targeting the sonic hedgehog signaling pathway: Review
of smoothened and GLI inhibitors. Cancers (Basel). 8(pii): E222016.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Qin S, Sun D, Li H, Li X, Pan W, Yan C,
Tang R and Liu X: The effect of SHH-Gli signaling pathway on the
synovial fibroblast proliferation in rheumatoid arthritis.
Inflammation. 39:503–512. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Skoda AM, Simovic D, Karin V, Kardum V,
Vranic S and Serman L: The role of the Hedgehog signaling pathway
in cancer: A comprehensive review. Bosn J Basic Med Sci. 18:8–20.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gu J, Saiyin H, Fu D and Li J: Stroma-a
double-edged sword in pancreatic cancer: A lesson from targeting
stroma in pancreatic cancer with hedgehog signaling inhibitors.
Pancreas. 47:382–389. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tong W, Qiu L, Qi M, Liu J, Hu K, Lin W,
Huang Y and Fu J: GANT-61 and GDC-0449 induce apoptosis of prostate
cancer stem cells through a GLI-dependent mechanism. J Cell
Biochem. 119:3641–3652. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ding J, Zhou XT, Zou HY and Wu J: Hedgehog
signaling pathway affects the sensitivity of hepatoma cells to drug
therapy through the ABCC1 transporter. Lab Invest. 97:819–832.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Song X, Yan L, Lu C, Zhang C, Zhu F, Yang
J, Jing H, Zhang Y, Qiao J and Guo H: Activation of hedgehog
signaling and its association with cisplatin resistance in ovarian
epithelial tumors. Oncol Lett. 15:5569–5576. 2018.PubMed/NCBI
|
|
17
|
Wang X, Wei S, Zhao Y, Shi C, Liu P, Zhang
C, Lei Y, Zhang B, Bai B and Huang Y: Anti-proliferation of breast
cancer cells with itraconazole: Hedgehog pathway inhibition induces
apoptosis and autophagic cell death. Cancer Lett. 385:128–136.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jones S, Zhang X, Parsons DW, Lin JC,
Leary RJ, Angenendt P, Mankoo P, Carter H, Kamiyama H, Jimeno A, et
al: Core signaling pathways in human pancreatic cancers revealed by
global genomic analyses. Science. 321:1801–1806. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pasca di Magliano M, Sekine S, Ermilov A,
Ferris J, Dlugosz AA and Hebrok M: Hedgehog/Ras interactions
regulate early stages of pancreatic cancer. Genes Dev.
20:3161–3173. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gan H, Liu H, Zhang H, Li Y, Xu X, Xu X
and Xu J: SHh-Gli1 signaling pathway promotes cell survival by
mediating baculoviral IAP repeat-containing 3 (BIRC3) gene in
pancreatic cancer cells. Tumour Biol. 37:9943–9950. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Katoh Y and Katoh M: Hedgehog target
genes: Mechanisms of carcinogenesis induced by aberrant hedgehog
signaling activation. Curr Mol Med. 9:873–886. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Feldmann G, Dhara S, Fendrich V, Bedja D,
Beaty R, Mullendore M, Karikari C, Alvarez H, Iacobuzio-Donahue C,
Jimeno A, et al: Blockade of hedgehog signaling inhibits pancreatic
cancer invasion and metastases: A new paradigm for combination
therapy in solid cancers. Cancer Res. 67:2187–2196. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang J, Li Y, Zu XB, Chen MF and Qi L:
Dauricine can inhibit the activity of proliferation of urinary
tract tumor cells. Asian Pac J Trop Med. 5:973–976. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang Z, Li C, Wang X, Zhai C, Yi Z, Wang
L, Liu B, Du B, Wu H, Guo X, et al: Dauricine induces apoptosis,
inhibits proliferation and invasion through inhibiting NF-kappaB
signaling pathway in colon cancer cells. J Cell Physiol.
225:266–275. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen S, Liu L, Yang Y, Dai Z and Zeng F:
Metabolism of dauricine and identification of its main metabolites.
J Tongji Med Univ. 20:253–256. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang Y, Tian X, Xie X, Zhuang Y, Wu W and
Wang W: Expression and regulation of hedgehog signaling pathway in
pancreatic cancer. Langenbecks Arch Surg. 395:515–525. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li YH and Gong PL: Neuroprotective effect
of dauricine in cortical neuron culture exposed to hypoxia and
hypoglycemia: Involvement of correcting perturbed calcium
homeostasis. Can J Physiol Pharmacol. 85:621–627. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu QN, Zhang L, Gong PL, Yang XY and Zeng
FD: Inhibitory effects of dauricine on early afterdepolarizations
and L-type calcium current. Can J Physiol Pharmacol. 87:954–962.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhao J, Lian Y, Lu C, Jing L, Yuan H and
Peng S: Inhibitory effects of a bisbenzylisoquinline alkaloid
dauricine on HERG potassium channels. J Ethnopharmacol.
141:685–691. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhou ZG, Zhang CY, Fei HX, Zhong LL and
Bai Y: Phenolic alkaloids from Menispermum dauricum inhibits
BxPC-3 pancreatic cancer cells by blocking of Hedgehog signaling
pathway. Pharmacogn Mag. 11:690–697. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang S, Ren Y and Qiu J: Dauricine
inhibits viability and induces cell cycle arrest and apoptosis via
inhibiting the PI3K/Akt signaling pathway in renal cell carcinoma
cells. Mol Med Rep. 17:7403–7408. 2018.PubMed/NCBI
|
|
32
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tang XD, Zhou X and Zhou KY: Dauricine
inhibits insulin-like growth factor-I-induced hypoxia inducible
factor 1alpha protein accumulation and vascular endothelial growth
factor expression in human breast cancer cells. Acta Pharmacol Sin.
30:605–616. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Deveci HA, Nazıroğlu M and Nur G:
5-Fluorouracil-induced mitochondrial oxidative cytotoxicity and
apoptosis are increased in MCF-7 human breast cancer cells by TRPV1
channel activation but not Hypericum perforatum treatment. Mol Cell
Biochem. 439:189–198. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Cunningham TJ, Tabacchi M, Eliane JP,
Tuchayi SM, Manivasagam S, Mirzaalian H, Turkoz A, Kopan R,
Schaffer A, Saavedra AP, et al: Randomized trial of calcipotriol
combined with 5-fluorouracil for skin cancer precursor
immunotherapy. J Clin Invest. 127:106–116. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Mahlberg R, Lorenzen S, Thuss-Patience P,
Heinemann V, Pfeiffer P and Möhler M: New perspectives in the
treatment of advanced gastric cancer: S-1 as a novel oral 5-fu
therapy in combination with cisplatin. Chemotherapy. 62:62–70.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liu J, Wang Z, Wu K, Li J, Chen W, Shen Y
and Guo S: Paclitaxel or 5-fluorouracil/esophageal stent
combinations as a novel approach for the treatment of esophageal
cancer. Biomaterials. 53:592–599. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Bash-Imam Z, Thérizols G, Vincent A,
Lafôrets F, Polay Espinoza M, Pion N, Macari F, Pannequin J, David
A, Saurin JC, et al: Translational reprogramming of colorectal
cancer cells induced by 5-fluorouracil through a miRNA-dependent
mechanism. Oncotarget. 8:46219–46233. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Shim IK, Yi HJ, Yi HG, Lee CM, Lee YN,
Choi YJ, Jeong SY, Jun E, Hoffman RM, Cho DW and Kim SC:
Locally-applied 5-fluorouracil-loaded slow-release patch prevents
pancreatic cancer growth in an orthotopic mouse model. Oncotarget.
8:40140–40151. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Longley DB, Harkin DP and Johnston PG:
5-fluorouracil: Mechanisms of action and clinical strategies. Nat
Rev Cancer. 3:330–338. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wang Y, Han Q and Zhang H: Evaluation of
the toxicity of 5-fluorouracil on three digestive enzymes from the
view of side effects. Spectrochim Acta A Mol Biomol Spectrosc.
220:1171052019. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Esin E, Telli TA, Yuce D and Yalcin S: A
correlation study of fluorouracil pharmacodynamics with clinical
efficacy and toxicity. Tumori. 104:157–164. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Jin H, Dai J, Chen X, Liu J, Zhong D, Gu Y
and Zheng J: Pulmonary toxicity and metabolic activation of
dauricine in CD-1 mice. J Pharmacol Exp Ther. 332:738–746. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Mohler J: Requirements for hedgehog, a
segmental polarity gene, in patterning larval and adult cuticle of
Drosophila. Genetics. 120:1061–1072. 1988.PubMed/NCBI
|
|
45
|
Du Z, Zhou F, Jia Z, Zheng B, Han S, Cheng
J, Zhu G and Huang P: The hedgehog/Gli-1 signaling pathways is
involved in the inhibitory effect of resveratrol on human
colorectal cancer HCT116 cells. Iran J Basic Med Sci. 19:1171–1176.
2016.PubMed/NCBI
|
|
46
|
Mizukoshi K, Koyama N, Hayashi T, Zheng L,
Matsuura S and Kashimata M: Shh/Ptch and EGF/ErbB cooperatively
regulate branching morphogenesis of fetal mouse submandibular
glands. Dev Biol. 412:278–287. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Wang LW, Lin H, Lu Y, Xia W, Gao J and Li
ZS: Sonic hedgehog expression in a rat model of chronic
pancreatitis. World J Gastroenterol. 20:4712–4717. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Kayed H, Kleeff J, Keleg S, Guo J,
Ketterer K, Berberat PO, Giese N, Esposito I, Giese T, Buchler MW
and Friess H: Indian hedgehog signaling pathway: Expression and
regulation in pancreatic cancer. Int J Cancer. 110:668–676. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Gao J, Li Z, Chen Z, Shao J, Zhang L, Xu
G, Tu Z and Gong Y: Antisense Smo under the control of the PTCH1
promoter delivered by an adenoviral vector inhibits the growth of
human pancreatic cancer. Gene Ther. 13:1587–1594. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Han JB, Hua YQ, Chen LY and Liu LM:
Advances in Smoothened-targeting therapies for pancreatic cancer:
Implication for drug discovery from herbal medicines. Zhong Xi Yi
Jie He Xue Bao. 10:256–263. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Lee HJ, Wu Q, Li H, Bae GU, Kim AK and Ryu
JH: A sesquiterpene lactone from Siegesbeckia glabrescens
suppresses Hedgehog/Gli-mediated transcription in pancreatic cancer
cells. Oncol Lett. 12:2912–2917. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Bai CB, Stephen D and Joyner AL: All mouse
ventral spinal cord patterning by hedgehog is Gli dependent and
involves an activator function of Gli3. Dev Cell. 6:103–115. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Gupta S, Takebe N and Lorusso P: Targeting
the Hedgehog pathway in cancer. Ther Adv Med Oncol. 2:237–250.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Hao K, Tian XD, Qin CF, Xie XH and Yang
YM: Hedgehog signaling pathway regulates human pancreatic cancer
cell proliferation and metastasis. Oncol Rep. 29:1124–1132. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Hidalgo M and Maitra A: The hedgehog
pathway and pancreatic cancer. N Engl J Med. 361:2094–2096. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Kelleher FC: Hedgehog signaling and
therapeutics in pancreatic cancer. Carcinogenesis. 32:445–451.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Dosch JS, Pasca di Magliano M and Simeone
DM: Pancreatic cancer and hedgehog pathway signaling: New insights.
Pancreatology. 10:151–157. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Zheng W, Lu S, Cai H, Kang M, Qin W, Li C
and Wu Y: Deguelin inhibits proliferation and migration of human
pancreatic cancer cells in vitro targeting hedgehog pathway. Oncol
Lett. 12:2761–2765. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Lennerz JK and Stenzinger A: Allelic ratio
of KRAS mutations in pancreatic cancer. Oncologist. 20:e8–e9. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Agarwal A and Saif MW: KRAS in pancreatic
cancer. Jop. 15:303–305. 2014.PubMed/NCBI
|
